8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Dexcom ($DXCM) issued a press release on Feb 12, 2026 announcing financial results for Q4 and FY ended Dec…
Filed with the SEC on · Summarized by InvestorsBot
Dexcom ($DXCM) issued a press release on Feb 12, 2026 announcing financial results for Q4 and FY ended Dec 31, 2025; release furnished as Exhibit 99.1 — check for revenue, EPS, guidance and other material metrics. 🧾📈 #Dexcom #Healthcare
Note: the Item 2.02 disclosure (Exhibit 99.1) is furnished, not “filed” under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated — limits Section 18 liability. $DXCM ⚖️ #SEC #8K